Substitution model of sequence evolution for the human immunodeficiency virus type 1 subtype B gp120 gene over the C2-V5 region

被引:15
|
作者
Anderson, JP [1 ]
Rodrigo, AG
Learn, GH
Wang, Y
Weinstock, H
Kalish, ML
Robbins, KE
Hood, L
Mullins, JI
机构
[1] Univ Washington, Hlth Sci Ctr, Dept Mol Biotechnol, Seattle, WA 98195 USA
[2] Univ Washington, Hlth Sci Ctr, Dept Microbiol, Seattle, WA 98195 USA
[3] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA
关键词
HIV-1; env; nucleotide substitution rates; rate heterogeneity; maximum likelihood; evolutionary model; simulations;
D O I
10.1007/s002390010192
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Phylogenetic analyses frequently rely on models of sequence evolution that detail nucleotide substitution rates, nucleotide frequencies, and site-to-site rate heterogeneity. These models can influence hypothesis testing and can affect the accuracy of phylogenetic inferences. Maximum likelihood methods of simultaneously constructing phylogenetic tree topologies and estimating model parameters are computationally intensive, and are not feasible for sample sizes of 25 or greater using personal computers. Techniques that initially construct a tree topology and then use this non-maximized topology to estimate ML substitution rates, however, can quickly arrive at a model of sequence evolution. The accuracy of this two-step estimation technique was tested using simulated data sets with known model parameters. The results showed that for a star-like topology, as is often seen in human immunodeficiency virus type 1 (HIV-1) subtype B sequences, a random starting topology could produce nucleotide substitution rates that were not statistically different than the true rates. Samples were isolated from 100 HIV-1 subtype B infected individuals from the United States and a 620 nt region of the env gene was sequenced for each sample. The sequence data were used to obtain a substitution model of sequence evolution specific for HIV-1 subtype B env by estimating nucleotide substitution rates and the site-to-site heterogeneity in 100 individuals from the United States. The method of estimating the model should provide users of large data sets with a way to quickly compute a model of sequence evolution, while the nucleotide substitution model we identified should prove useful in the phylogenetic analysis of HIV-1 subtype B env sequences.
引用
收藏
页码:55 / 62
页数:8
相关论文
共 50 条
  • [21] Peptidomimetic inhibitors targeting the CCR5-binding site on the human immunodeficiency virus type-1 gp120 glycoprotein complexed to CD4
    Seitz, Markus
    Rusert, Peter
    Moehle, Kerstin
    Trkola, Alexandra
    Robinson, John A.
    CHEMICAL COMMUNICATIONS, 2010, 46 (41) : 7754 - 7756
  • [22] A Rat Model of Human Immunodeficiency Virus 1 Encephalopathy Using Envelope Glycoprotein gp120 Expression Delivered by SV40 Vectors
    Louboutin, Jean-Pierre
    Agrawal, Lokesh
    Reyes, Beverly A. S.
    Van Bockstaele, Elisabeth J.
    Strayer, David S.
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2009, 68 (05) : 456 - 473
  • [23] Structure-Function Analysis of Human Immunodeficiency Virus Type 1 gp120 Amino Acid Mutations Associated with Resistance to the CCR5 Coreceptor Antagonist Vicriviroc
    Ogert, Robert A.
    Ba, Lei
    Hou, Yan
    Buontempo, Catherine
    Qiu, Ping
    Duca, Jose
    Murgolo, Nicholas
    Buontempo, Peter
    Ralston, Robert
    Howe, John A.
    JOURNAL OF VIROLOGY, 2009, 83 (23) : 12151 - 12163
  • [24] Env sequence determinants in CXCR4-using human immunodeficiency virus type-1 subtype C
    Lin, Nina H.
    Becerril, Carlos
    Giguel, Francoise
    Novitsky, Vladimir
    Moyo, Sikhulile
    Makhema, Joseph
    Essex, Myron
    Lockman, Shahin
    Kuritzkes, Daniel R.
    Sagar, Manish
    VIROLOGY, 2012, 433 (02) : 296 - 307
  • [25] Human immunodeficiency virus type 1 gp120 envelope characteristics associated with disease progression differ in family members infected with genetically similar viruses
    Baan, Elly
    van der Sluis, Renee M.
    Bakker, Margreet E.
    Bekker, Vincent
    Pajkrt, Dasja
    Jurriaans, Suzanne
    Kuijpers, Taco W.
    Berkhout, Ben
    Wolthers, Katja C.
    Paxton, William A.
    Pollakis, Georgios
    JOURNAL OF GENERAL VIROLOGY, 2013, 94 : 20 - 29
  • [26] Adenovirus-Vectored Broadly Neutralizing Antibodies Directed Against gp120 Prevent Human Immunodeficiency Virus Type 1 Acquisition in Humanized Mice
    Liu, Shan
    Jackson, Andrew
    Beloor, Jagadish
    Kumar, Priti
    Sutton, Richard E.
    HUMAN GENE THERAPY, 2015, 26 (09) : 622 - 634
  • [27] Mapping resistance to the CCR5 co-receptor antagonist vicriviroc using heterologous chimeric HIV-1 envelope genes reveals key determinants in the C2-V5 domain of gp120
    Ogert, Robert A.
    Wojcik, Lisa
    Buontempo, Catherine
    Ba, Lei
    Buontempo, Peter
    Ralston, Robert
    Strizki, Julie
    Howe, John A.
    VIROLOGY, 2008, 373 (02) : 387 - 399
  • [28] Emergence of gp120 V3 Variants Confers Neutralization Resistance in an R5 Simian-Human Immunodeficiency Virus-Infected Macaque Elite Neutralizer That Targets the N332 Glycan of the Human Immunodeficiency Virus Type 1 Envelope Glycoprotein
    Sadjadpour, Reza
    Donau, Olivia K.
    Shingai, Masashi
    Buckler-White, Alicia
    Kao, Sandra
    Strebel, Klaus
    Nishimura, Yoshiaki
    Martin, Malcolm A.
    JOURNAL OF VIROLOGY, 2013, 87 (15) : 8798 - 8804
  • [29] Bifunctional Chimera That Coordinately Targets Human Immunodeficiency Virus 1 Envelope gp120 and the Host-Cell CCR5 Coreceptor at the Virus-Cell Interface
    Rashad, Adel A.
    Song, Li-Rui
    Holmes, Andrew P.
    Acharya, Kriti
    Zhang, Shiyu
    Wang, Zhi-Long
    Gary, Ebony
    Xie, Xin
    Pirrone, Vanessa
    Kutzler, Michele A.
    Long, Ya-Qiu
    Chaiken, Irwin
    JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (11) : 5020 - 5033
  • [30] Divergent Primary Immune Responses Induced by Human Immunodeficiency Virus-1 gp120 and Hepatitis B Surface Antigen Determine Antibody Recall Responses
    Yuan, Li
    Chen, Wen-Jiang
    Wang, Jia-Ye
    Li, Yan
    Tian, Dan
    Wang, Ming-Xia
    Yu, Hao-Tong
    Xu, Ying-Chu
    Li, Di
    Zhuang, Min
    Ling, Hong
    VIROLOGICA SINICA, 2018, 33 (06) : 502 - 514